Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 33, 2004 - Issue 4
72
Views
11
CrossRef citations to date
0
Altmetric
Original

Fructose‐1,6‐Diphosphate Suppresses T‐Lymphocyte Proliferation, Promotes Apoptosis and Inhibits Interleukins‐1, 6, β‐Actin mRNAs, and Transcription Factors Expression

, , , & , M.D.
Pages 407-421 | Published online: 26 Aug 2009
 

Abstract

The overall objective of this study was to determine the role fructose 1,6‐diphosphate (FDP), a naturally occurring glycolytic intermediate, plays in activated T‐lymphocytes. The hypothesis is twofold. First, we propose that FDP inhibits T cell proliferation to a greater extent than fructose‐1‐phosphate (F1P), fructose‐6‐phosphate (F6P) and mannose‐6‐phosphate (M6P); second, we argue that FDP suppresses immune activation by inhibiting inflammatory cytokine expression, inhibiting expression of key transcription factors, and by inducing apoptosis in immune cells. Rat spleen cells were incubated with concanavalin A (ConA) and increasing concentrations of FDP. Proliferation was determined by tritiated thymidine uptake. FDP inhibited splenocyte proliferation in a dose‐related manner while F1P, F6P, M6P demonstrated inhibition only at high concentrations (5000 µg/ml). RNA was harvested from FDP and ConA‐treated cells and IL‐1 and IL‐6 gene expression was analyzed by RT‐PCR. IL‐1 and IL‐6 mRNA expression was completely inhibited at 500–5000 µg/ml FDP. Apoptosis in FDP‐treated lymphocytes was determined by DNA fragmentation and flow cytometry. Propidium iodide (PI) staining demonstrated a 39% rate of apoptosis in splenocytes treated with ConA and 5000 µg/ml FDP. Extensive DNA fragmentation was present at 250–5000 µg/ml FDP, and maximal inhibition occurred at 5 µg/ml. F1P, F6P and M6P showed maximal inhibition only at 5000 µg/ml. Nuclear extracts from FDP‐treated splenocytes were analyzed by electrophoretic mobility shift assay. ConA activation of NF‐κB and AP‐1 was dramatically inhibited by FDP. Interestingly, β‐actin showed extensive inhibition with FDP and ConA, thus suggesting new possibilities of its being used as a therapeutic modality in arterial injury where the β‐actin, an important cytoskeleton element, plays a very important role. These data indicate that FDP may be a useful immunosuppressive agent. In conclusion, FDP is not only an immunosuppressant but also an anti‐inflammatory agent.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.